logo

For the Inventor, By the Inventor

St. Louis, MO, United States of America

Robert E Manning

USPTO Granted Patents = 57

 

Average Co-Inventor Count = 2.3

ph-index = 12

Forward Citations = 423(Granted Patents)

Forward Citations (Not Self Cited) = 408(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Thousand Oaks, CA (US) (1981)
  • St. Louis, MO (US) (1990 - 2006)
  • New York, NY (US) (2014)

Company Filing History:

goldMedal50 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal2 out of 200 
 
Pharmacia Corporation
 patents
bronzeMedal1 out of 6 
 
C. D. Searle & Co.
 patents
4. 1 out of 33 
 
G.d. Searle LLC
 patents
5. 3 out of 832,843 
Other
 patents

Years Active: 1981-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
Ink Jet Printing
Biphenylalkyl Compounds
Angiotensin II Antagonists
Nitric Oxide Synthase Inhibitors
Platelet Aggregation Inhibitors
Circulatory Disorders
Combination Therapy
Alkylamino Compounds
Pharmaceutical Compositions
Inflammation Treatment
HMG Co-A Reductase Inhibitors
Ileal Bile Acid Transport
57 patents (USPTO):Explore Patents
1. 8708437 - Ink jet multi-color printing system (2014-04-29),
2. 7132437 - Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension (2006-11-07),
3. 6943189 - Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG CO-A reductase inhibitors (2005-09-13),
4. 6858636 - 1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders (2005-02-22),
5. 6642268 - Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors (2003-11-04),
6. 6630497 - 1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders (2003-10-07),
7. 6576780 - Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors (2003-06-10),
8. 6492397 - N-arylheteroarylalkyl imidazol-2-one compounds for treatment of arteriosclerosis (2002-12-10),
9. 6451833 - N-substituted (&agr;-imidazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders (2002-09-17),
10. 6420417 - Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors (2002-07-16),
11. 6268392 - Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors (2001-07-31),
12. 6207708 - Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors (2001-03-27),
13. 6008368 - Pharmaceutical compositions for treatment of circulatory disorders using (1999-12-28),
14. 5981511 - Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors (1999-11-09),
15. 5945408 - Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors (1999-08-31),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees and patents, I'm here to help with your request. Let's delve into an article about the renowned inventor, Robert E Manning from St. Louis, MO (US).

Title:

The Innovation Trailblazer: Robert E Manning's Impactful Journey

Introduction:

Robert E Manning is a distinguished inventor based in St. Louis, MO, known for his groundbreaking contributions to the technological landscape. With an impressive portfolio of 57 patents, he continues to push boundaries and drive innovation.

Latest Patents:

Among his latest patents is the "Ink jet multi-color printing system," a cutting-edge system designed to optimize RGB digital color images for high-speed textile printing. This innovation combines modular single-color ink jet print engines with a rotary screen, offering a diverse range of printing modes and effects.

Another notable invention is the "Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension." This patent focuses on renal-selective compounds that target angiotensin II receptors in the kidney, showcasing Manning's expertise in the medical field.

Career Highlights:

Robert E Manning has made significant contributions during his tenure at G.D. Searle & Company, where his inventive spirit has led to groundbreaking solutions in various industries. His innovative approach and dedication to research have set him apart as a visionary inventor in the field.

Collaborations:

Throughout his career, Manning has collaborated with esteemed professionals such as Gunnar J Hanson and David B Reitz. These partnerships have fostered creativity and driven forward-thinking initiatives, resulting in impactful inventions that have revolutionized their respective fields.

Conclusion:

In conclusion, Robert E Manning stands as a beacon of innovation in the technological landscape, with a remarkable track record of pioneering inventions that have left a lasting impact on society. His relentless pursuit of innovation continues to inspire aspiring inventors worldwide.

If you have any more requests or need further information on innovations, inventions, inventors, patent attorneys, assignees, or patents, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…